{
  "config_hash": "b48218b5a4fbbfb6",
  "seed": 42,
  "completed_indices": [
    2
  ],
  "results": {
    "2": {
      "coral_idx": 142,
      "note_text": "Medical Oncology Consult Note  Video Consult    Patient Name: ***** *****   ***** *****:  *****   Patient DOB:  02/12/1968   Date of Visit:  08/31/2021  Provider:  ***** ***** *****  Primary Care Provider:  Name Unknown Provider  Referring MD:        Reason for visit:   Chief Complaint   Patient presents with   \u0007 New Patient Evaluation       Diagnosis:    1. Malignant neoplasm of upper-outer quadrant of right breast in female, estrogen receptor positive (CMS code)         I have collected verbal consent for care and acknowledgement of patient financial responsibility at the outset of this video encounter.    History of Present Illness:     53 year old female with a mammogram detected right breast cancer.  She had a right breast and axillary lymph node that were positive for HR+ her 2 neu negative IDC ( 1.7 cm on imaging at 10 o clock with a 1.5 cm lymph node,  *****, HR+, her 2 2+, fish negative.  ***** 67 30-35%) and she saw Dr. ***** ***** who recommended neoadjuvant therapy.  She has had several opinions and is here for a medical oncology consult.     She is scheduled for a pet ct and genetic testing.  She had an echo yesterday.   She reports being pre *****.  ***** ***** has been sent and is pending.  We discussed how she does not qualify for ISPY. She lives by ***** but is deciding where to be treated.      Oncologic history    Stage at *****:  Cancer Staging  Malignant neoplasm of upper-outer quadrant of right breast in female, estrogen receptor positive (CMS code)  Staging form: Breast, AJCC 8th Edition  - Clinical: Stage IIA (*****, *****, *****, *****, ER+, PR+, *****-) - Signed by ***** ***** *****, DO on 08/20/2021      Medications:  No current outpatient medications on file.    Allergies: Allergies/Contraindications  No Known Allergies    Medical History:   Past Medical History:   Diagnosis Date   \u0007 Hyperlipidemia    \u0007 Pre-diabetes        Surgical History: History reviewed. No pertinent surgical \n history.    Social History:   Social History     Tobacco Use   \u0007 Smoking status: Never Smoker   \u0007 Smokeless tobacco: Not on file   Substance and Sexual Activity   \u0007 Alcohol use: Never   \u0007 Drug use: Never   \u0007 Sexual activity: Not on file   Social History Narrative   \u0007 Not on file       *****:  *****     ***** Status: single     Gynecologic History:  G 0 P 0 AB 0    Menarche 10  Menopause  50   OCP 0 years HRT 0 years   Fertility treatments 0    Family History:   Family History   Problem Relation Name Age of Onset   \u0007 Leukemia Father     \u0007 Breast cancer Paternal Aunt  60   \u0007 Breast cancer Maternal Aunt                 Review of systems:  CONSTITUTIONAL: No fevers, chills, night sweats, loss of appetite or weight loss  H/E/N/T:  No headaches, vision changes, mouth sores  CV: No *****, orthopnea  PULM: No cough, hemoptysis or sob.   ABD:  No abdominal pain, nausea, vomiting, diarrhea, or bleeding  GU:  No dysuria or hematuria  SKIN:  No rash or bruising  NEURO:  No difficulty with speech, balance, or gait, no headache  MUSC:  No joint pain  PSYCH:  No depression, or anxiety or trouble sleeping.     Pain    Pain Score/Location    08/31/21 1500   *****:  0       Code status: full code.     Performance status:  0 - Asymptomatic    Physical exam:  There were no vitals taken for this visit.  GEN: No acute distress, awake and alert, appears stated age    Labs:    No visits with results within 1 Month(s) from this visit.   Latest known visit with results is:   No results found for any previous visit.    Lifestyle:  Exercise walks occasionally  Diet moderate sweet tooth.  Sleep:  5-6 hours takes ***** 5 mg.   Stress: medium     Psychologic/emotional well-being/support  She has good support.     Assessment / Plan:    1. Stage IIA right IDC of the breast 1.7 cm, node positive, HR+, her 2 neu negative by FISH.    2. ***** sent and is pending. We discussed the role of chemotherapy to decrease the risk of \n systemic recurrence.  3.  We discussed the role of surgery and radiation to decrease the risk of local recurrence.  4.  We discussed the role of hormonal blockade to decrease the risk of systemic recurrence.    5.  We discussed lifestyle modifications to decrease the risk of recurrence as well as primary cancer risk reduction.  I recommend an anti inflammatory and /or diabetes risk reducing diet , limiting alcohol, exercise, stress reduction and sleep management.   6.  Genetic testing sent and is pending.   7.  ***** follow up after pet and ***** are back.         ***** ***** *****, MD  Medical Oncology/Hematology    TIME SPENT: I spent a total of 70 minutes on this patient's care on the day of their visit excluding time spent related to any billed procedures. This time includes face-to-face time with the patient as well as time spent documenting in the medical record, reviewing patient's records and tests, obtaining history, placing orders, communicating with other healthcare professionals, counseling the patient, family, or caregiver, and/or care coordination for the diagnoses above.      I performed this evaluation using real-time telehealth tools, including a live video Zoom connection between my location and the patient's location. Prior to initiating, the patient consented to perform this evaluation using telehealth tools.        \n",
      "assessment_and_plan": "Assessment / Plan:    1. Stage IIA right IDC of the breast 1.7 cm, node positive, HR+, her 2 neu negative by FISH.    2. ***** sent and is pending. We discussed the role of chemotherapy to decrease the risk of \n systemic recurrence.  3.  We discussed the role of surgery and radiation to decrease the risk of local recurrence.  4.  We discussed the role of hormonal blockade to decrease the risk of systemic recurrence.    5.  We discussed lifestyle modifications to decrease the risk of recurrence as well as primary cancer risk reduction.  I recommend an anti inflammatory and /or diabetes risk reducing diet , limiting alcohol, exercise, stress reduction and sleep management.   6.  Genetic testing sent and is pending.   7.  ***** follow up after pet and ***** are back.         ***** ***** *****, MD  Medical Oncology/Hematology    TIME SPENT: I spent a total of 70 minutes on this patient's care on the day of their visit excluding time spent related to any billed procedures. This time includes face-to-face time with the patient as well as time spent documenting in the medical record, reviewing patient's records and tests, obtaining history, placing orders, communicating with other healthcare professionals, counseling the patient, family, or caregiver, and/or care coordination for the diagnoses above.      I performed this evaluation using real-time telehealth tools, including a live video Zoom connection between my location and the patient's location. Prior to initiating, the patient consented to perform this evaluation using telehealth tools.        \n",
      "keypoints": {
        "Reason_for_Visit": {
          "Patient type": "New patient",
          "second opinion": "Yes",
          "in-person": "Televisit",
          "summary": "New patient evaluation for Malignant neoplasm of upper-outer quadrant of right breast in female, estrogen receptor positive, Stage IIA, for a medical oncology consult"
        },
        "What_We_Found": {
          "Type_of_Cancer": "Malignant neoplasm of upper-outer quadrant of right breast in female, estrogen receptor positive",
          "Stage_of_Cancer": "Stage IIA",
          "Distant Metastasis": "No",
          "Metastasis": "No",
          "lab_summary": "",
          "findings": "53 year old female with a 1.7 cm IDC in the right breast and a 1.5 cm lymph node, HR+, HER2 negative by FISH"
        },
        "Treatment_Summary": {
          "current_meds": "",
          "recent_changes": "",
          "supportive_meds": ""
        },
        "Goals_of_care": {
          "goals_of_treatment": "decrease the risk of systemic recurrence",
          "response_assessment": "We discussed the role of chemotherapy, surgery, radiation, hormonal blockade, and lifestyle modifications to decrease the risk of systemic recurrence"
        },
        "Medication_Plan_chatgpt": {
          "bowel regimen": {
            "summary": "recommend an anti inflammatory and/or diabetes risk reducing diet",
            "Short term side_effects_discussed": null,
            "Long term side_effects_discussed": null
          },
          "other treatment": {
            "summary": "limiting alcohol, exercise, stress reduction and sleep management",
            "Short term side_effects_discussed": null,
            "Long term side_effects_discussed": null
          }
        },
        "Medication_Plan": {
          "medication_plan": "No medication plan is mentioned in the note, only lifestyle modifications are recommended."
        },
        "Therapy_plan": {
          "therapy_plan": "Chemotherapy was discussed as a role in the treatment plan to decrease the risk of systemic recurrence, radiotherapy was discussed as a role in the treatment plan to decrease the risk of local recurrence, and hormonal therapy was discussed as a role in the treatment plan to decrease the risk of systemic recurrence."
        },
        "radiotherapy_plan": {
          "radiotherapy_plan": "discussed the role of surgery and radiation to decrease the risk of local recurrence"
        },
        "Procedure_Plan": {
          "procedure_plan": "No procedures planned."
        },
        "Imaging_Plan": {
          "imaging_plan": "PET and PET are pending."
        },
        "Lab_Plan": {
          "lab_plan": "Genetic testing is pending."
        },
        "Genetic_Testing_Plan": {
          "genetic_testing_plan": "Genetic testing is pending."
        },
        "Referral": {
          "Nutrition": "None",
          "Genetics": "Genetic testing is pending",
          "Specialty": "None",
          "Others": "None",
          "follow up": "None"
        },
        "follow_up_next_visit": {
          "Next clinic visit": "follow up after PET and PET are back"
        },
        "Advance_care_planning": {
          "Advance care": "Not discussed during this visit."
        }
      }
    }
  },
  "completed": false
}